Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds

NCT01657292 is registered in ClinicalTrials.gov with Birken AG as lead sponsor.

NCT NCT01657292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01657292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds
Lead sponsor
Birken AG
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
July 31, 2014
Enrollment
61 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

burns